What is the significance of a 63-year-old female's Papanicolaou (PAP) test results showing atrophic pattern, predominantly parabasal cells, and negative for intraepithelial lesion or malignancy, with partially obscuring inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025 • View editorial policy

From the Research

The Pap test results are normal, showing no signs of cervical cancer or precancerous changes, and no immediate action is required based on these findings. The report indicates an "atrophic pattern" with predominantly parabasal cells, which is a common and expected finding in a 63-year-old woman due to lower estrogen levels after menopause, as supported by the study on vacuolated parabasal cells in Papanicolaou smears 1. This atrophic pattern can sometimes cause mild inflammation, which was noted as "partially obscuring" but did not prevent proper evaluation of the sample. It's essential to note that the presence of parabasal cells, even in the context of atrophy, does not necessarily indicate an abnormality, and the study on vacuolated parabasal cells highlights the association of specific cellular changes with human papillomavirus (HPV) infection, particularly HPV16 1. However, in this case, the cytology results are negative for intraepithelial lesion or malignancy, which is the primary concern in cervical cancer screening.

Key points to consider:

  • The patient's age and the atrophic pattern are consistent with expected menopausal changes.
  • The inflammation noted is mild and did not compromise the evaluation of the sample.
  • The study on vacuolated parabasal cells and HPV infection 1 provides insight into cellular changes associated with HPV but does not directly apply to this patient's normal screening results.
  • Routine cervical cancer screening should continue as recommended by the healthcare provider, typically every 3-5 years for women in this age group.
  • Symptoms related to vaginal atrophy, such as dryness or irritation, should be discussed with a doctor for appropriate management, but these are separate from the cancer screening findings.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.